$0.10 0.2%
ZOM Stock Price vs. AI Score
Data gathered: April 27

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

AI Stock Analysis - Zomedica (ZOM)

Analysis generated February 5, 2025. Powered by Chat GPT.

Zomedica Corp. is a veterinary health company that specializes in meeting the needs of clinical veterinarians. The company provides diagnostic and therapeutic products that are designed to improve the quality of care for companion animals. Zomedica's product portfolio includes diagnostics and innovative technologies specifically tailored for the veterinary industry.

Read full AI stock Analysis

Stock Alerts - Zomedica (ZOM)

company logo Zomedica | March 20
Insider Alert: Jordan Scott is buying shares
company logo Zomedica | March 19
Insider Alert: MACLEOD CHRISTOPHER ROSS is buying shares
company logo Zomedica | March 11
Over the past few months, there has been an downward trend in the business outlook.
company logo Zomedica | March 3
Price is down by -6.3% in the last 24h.

About Zomedica

Zomedica is a veterinary health company focused on meeting the needs of clinical veterinarians in ways that promote both patient and practice health.


Zomedica
Price $0.10
Target Price Sign up
Volume 790,940
Market Cap $148M
Year Range $0.1 - $0.15
Dividend Yield 0%
Analyst Rating 0% buy
Industry Drug Manufacturers

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '247M1.9M5.1M-6.7M-5.8M-0.007
Q2 '246.1M1.8M4.4M-24M-23M-0.024
Q1 '246.3M2.1M4.1M-9.2M-8.8M-0.010
Q4 '237.3M2.3M5.1M-22M-20M-0.010
Q3 '236.3M2M4.4M-490,000-950,000-0.001

Insider Transactions View All

Rowe Jeffrey M filed to buy 1,679,280 shares at $0.1.
March 18 '25
HEATON LARRY C II filed to buy 510,000 shares at $0.1.
March 18 '25
POWERS JOHNNY D filed to buy 2,825,000 shares at $0.1.
March 18 '25
Rowe Jeffrey M filed to buy 1,714,005 shares at $0.1.
March 18 '25
Rowe Jeffrey M filed to buy 943,647 shares at $0.1.
March 18 '25

What is the Market Cap of Zomedica?

The Market Cap of Zomedica is $148M.

What is the current stock price of Zomedica?

Currently, the price of one share of Zomedica stock is $0.10.

How can I analyze the ZOM stock price chart for investment decisions?

The ZOM stock price chart above provides a comprehensive visual representation of Zomedica's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Zomedica shares. Our platform offers an up-to-date ZOM stock price chart, along with technical data analysis and alternative data insights.

Does ZOM offer dividends to its shareholders?

As of our latest update, Zomedica (ZOM) does not offer dividends to its shareholders. Investors interested in Zomedica should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Zomedica?

Some of the similar stocks of Zomedica are Johnson & Johnson, Eli Lilly and Company, Pfizer, Astrazeneca, and AbbVie.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2025 AltIndex. All rights reserved.